VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Valar Atomics Triples to $6B for Factory Nuclear
Value Add VC/Pulse/FUNDING$1B Series B

Valar Atomics Triples to $6B for Factory Nuclear

Valar Atomics raised a $1B Series B led by Sequoia at a $6B valuation, tripling its mark since April, months after using a fission reaction to power an Nvidia chip for the first time.

By the Numbers

$1B Series B
Round
$6B
Valuation
$2B
Prior valuation (Apr)
$200M
Credit facility
TC
By the Funding Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
August 4, 2026
1 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

A live fission reaction powering an actual Nvidia chip is the proof point that justifies tripling a valuation in four months -- most nuclear-for-AI startups are still selling a roadmap, not a demo. The number I'd want before the next markup is an actual NRC licensing application date, not a factory-production target; licensing timelines are where every nuclear startup's promises have historically gone to die, and Valar hasn't said one publicly yet.

Analysis

From Proof of Concept to Factory Reactors

Valar Atomics raised a $1 billion Series B led by Sequoia Capital, tripling its valuation to $6 billion just four months after a $450 million round priced it at $2 billion, according to TechCrunch. The Los Alamos, New Mexico-based company separately closed a $200 million credit facility led by Erebor Bank and JPMorgan, bringing its newly announced financing to $1.2 billion. Sequoia partner Shaun Maguire is joining Valar's board.

“Investors in the round include Apandion, Atreides, Conviction, Dream Ventures, HOF Capital, Point72, Riot Ventures, Snowpoint Ventures and Valor Equity Partners.”

The valuation jump follows a real technical milestone, not just investor enthusiasm: in July, Valar used a nuclear fission reaction to generate enough electricity to power an Nvidia AI chip and host a website, according to Bloomberg. That is a small-scale demonstration, not a licensed commercial reactor, but it is the kind of concrete proof point that separates Valar from the many nuclear-for-AI startups still years from any working hardware.

Valar's plan is to move from proving the technology works to mass-producing small factory-built reactors, with AI data centers as one of its largest target markets -- the same demand driving this week's Texas grid moratorium and Base Power's own $1 billion raise. Investors in the round include Apandion, Atreides, Conviction, Dream Ventures, HOF Capital, Point72, Riot Ventures, Snowpoint Ventures and Valor Equity Partners.

The honest caveat: no US startup has a commercially licensed small modular reactor operating today, and NRC licensing timelines for new reactor designs have historically run years longer than founders promise investors. What to watch: whether Valar discloses an actual NRC licensing application timeline, not just a factory-production target.

ShareXLinkedInEmail

More on

Nvidia →Sequoia Capital →Valar Atomics →

Reported by TechCrunch · First reported by Bloomberg · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

FUNDING· Aug 15, 2026

Why VCs' Biggest August Checks Went to Reactors, Not Apps

Illustration for: Why VCs' Biggest August Checks Went to Reactors, Not Apps
FUNDING

Why VCs' Biggest August Checks Went to Reactors, Not Apps

Five of the month's largest venture rounds funded nuclear reactors, home batteries, GPU-training infrastructure and automated factories rather than software, a distribution that says more about where capital is scarce than about any single pitch deck.

FUNDING· Aug 13, 2026

Bridge to Life Raises $110M for Organ Preservation

Illustration for: Bridge to Life Raises $110M for Organ Preservation
FUNDING$110M Series C

Bridge to Life Raises $110M for Organ Preservation

Bridge to Life closed $110 million in Series C equity funding plus additional debt financing for its organ preservation and perfusion technology, part of a broader wave of biotech capital chasing transplant and longevity-adjacent medtech in 2026.

FUNDING· Aug 15, 2026

AI Coding Tools Have Minted Five $1B+ Companies

Illustration for: AI Coding Tools Have Minted Five $1B+ Companies
FUNDING

AI Coding Tools Have Minted Five $1B+ Companies

Five AI coding-tool startups now carry valuations above $1 billion after this month's rounds, a cluster of pricing that says more about how much capital is chasing the category than about any one company's product lead.

@Trace_Cohen·t@nyvp.com